Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Mazer BD et al. | Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine on B lymphocytes. | 1998 | J. Allergy Clin. Immunol. | pmid:9723666 |
Beyer AJ et al. | PAF and CD18 mediate neutrophil infiltration in upper gastrointestinal tract during intra-abdominal sepsis. | 1998 | Am. J. Physiol. | pmid:9724257 |
Rougier F and Denizot Y | Platelet-activating factor and the growth of fibroblasts. | 1998 | Mol. Carcinog. | pmid:9726813 |
Matsumoto K et al. | Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke. | 1998 | Eur. Respir. J. | pmid:9727790 |
Ibe BO et al. | Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb. | 1998 | J. Appl. Physiol. | pmid:9729586 |
Qu XW et al. | Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. | 1998 | J. Physiol. (Lond.) | pmid:9729632 |
Ueno M et al. | Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen. | 1998 | Pharmacology | pmid:9730778 |
Burke-Gaffney A and Hellewell PG | A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. | 1998 | Am. J. Respir. Cell Mol. Biol. | pmid:9730868 |
M'Rabet L et al. | Activation of the small GTPase rap1 in human neutrophils. | 1998 | Blood | pmid:9731072 |
Cheryk LA et al. | Alterations in blood platelet morphology during aggregate formation in the Asian elephant (Elephas maximus). | 1998 | J. Zoo Wildl. Med. | pmid:9732033 |
Liu L et al. | Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. | 1998 | J. Immunol. | pmid:9743372 |
Kruse-Elliott KT et al. | Low molecular weight heparin alters porcine neutrophil responses to platelet-activating factor. | 1998 | Shock | pmid:9744648 |
Huang Q et al. | Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. | 1998 | Am. J. Physiol. | pmid:9746460 |
Rocha MF et al. | Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta. | 1998 | Infect. Immun. | pmid:9746596 |
Endo S et al. | Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment. | 1998 | Childs Nerv Syst | pmid:9753399 |
Heath MF et al. | Dextran-70 inhibits equine platelet aggregation induced by PAF but not by other agonists. | 1998 | Equine Vet. J. | pmid:9758098 |
El-Shazly A et al. | Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate. | 1998 | Int. Arch. Allergy Immunol. | pmid:9758889 |
Matsumoto K et al. | Altered expression of CD11b and CD62L after cross-linking of CD45 isoforms on human eosinophils. | 1998 | Int. Arch. Allergy Immunol. | pmid:9758894 |
El-Shazly A et al. | Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. | 1998 | Int. Arch. Allergy Immunol. | pmid:9758899 |
Kinn JW and Bache RJ | Effect of platelet activation on coronary collateral blood flow. | 1998 | Circulation | pmid:9760298 |
Tamm M et al. | Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. | 1998 | Am. J. Respir. Cell Mol. Biol. | pmid:9761763 |
Spoelstra FM et al. | Effect of theophylline on CD11b and L-selectin expression and density of eosinophils and neutrophils in vitro. | 1998 | Eur. Respir. J. | pmid:9762784 |
Kabasakal C et al. | The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. | 1998 Jul-Sep | Turk. J. Pediatr. | pmid:9763906 |
Marriott I et al. | Differential kinetics for induction of interleukin-6 mRNA expression in murine peritoneal macrophages: evidence for calcium-dependent and independent-signalling pathways. | 1998 | J. Cell. Physiol. | pmid:9766520 |
Bozza PT et al. | Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. | 1998 | J. Leukoc. Biol. | pmid:9766638 |
Kern H et al. | Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. | 1998 | Biochim. Biophys. Acta | pmid:9767093 |
Le Blanc K et al. | Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera. | 1998 | Thromb. Res. | pmid:9772010 |
Abu-Zidan FM | Hope or hype for lexipafant? | 1998 | Nature | pmid:9774090 |
Perez S et al. | Inhibition by the anti-mitotic drug doxorubicin of platelet-activating-factor-induced late eosinophil accumulation in rats. | 1998 | Eur. J. Pharmacol. | pmid:9774255 |
Teather LA et al. | Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory. | 1998 | Neurobiol Learn Mem | pmid:9774526 |
Suzuki T et al. | 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists. | 1998 | Chem. Pharm. Bull. | pmid:9775441 |
Shah BH et al. | The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. | 1998 | Biochem. Pharmacol. | pmid:9776305 |
Serebruany VL et al. | Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction. | 1998 | Cardiology | pmid:9778550 |
Akisü M et al. | The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury. | 1998 | Acta Med. Okayama | pmid:9781268 |
SariahmetoÄŸlu M et al. | Effects of WEB 2086 on the protective role of preconditioning against arrhythmias in rats. | 1998 | Pharmacol. Res. | pmid:9782066 |
Carlson SA and Jones BD | Inhibition of Salmonella typhimurium invasion by host cell expression of secreted bacterial invasion proteins. | 1998 | Infect. Immun. | pmid:9784535 |
Akisü M et al. | Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. | 1998 | Biol. Neonate | pmid:9784635 |
Momose T et al. | Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression. | 1998 | Int. Arch. Allergy Immunol. | pmid:9784658 |
O'Neill C | Role of autocrine mediators in the regulation of embryo viability: lessons from animal models. | 1998 | J. Assist. Reprod. Genet. | pmid:9785192 |
Kaneshiro ES et al. | Characterizations of Pneumocystis carinii and rat lung lipids: glyceryl ethers and fatty alcohols. | 1998 | J. Lipid Res. | pmid:9788237 |
Ohno Y et al. | Effects of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig. | 1998 | Ann. Otol. Rhinol. Laryngol. | pmid:9794619 |
Pestonjamasp VK and Burstein SH | Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. | 1998 | Biochim. Biophys. Acta | pmid:9795237 |
Hofbauer B et al. | Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. | 1998 | Gastroenterology | pmid:9797380 |
Templeton AG et al. | Effects of S-salbutamol on human isolated bronchus. | 1998 | Pulm Pharmacol Ther | pmid:9802957 |
Choi IH et al. | Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. | 1998 | J. Exp. Med. | pmid:9802970 |
Izzo AA et al. | Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. | 1998 | Trends Pharmacol. Sci. | pmid:9803830 |
Aida Y et al. | Effects of chroman derivatives on platelet aggregation induced by some aggregating agents in rabbits. | 1998 | Clin. Exp. Pharmacol. Physiol. | pmid:9807668 |
Montrucchio G et al. | Potential angiogenic role of platelet-activating factor in human breast cancer. | 1998 | Am. J. Pathol. | pmid:9811351 |
Denizot Y et al. | Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells. | 1998 | Cytokine | pmid:9811531 |
Song SQ and Hu YM | Effects of tetrandrine, Fura 2-AM, and Bay k 8644 on platelet-activating factor release from rat peritoneal macrophages stimulated by lipopolysaccharides. | 1996 | Zhongguo Yao Li Xue Bao | pmid:9812743 |